initial expression of HSV-1 ␣ genes depends on the binding of the ␣ trans-induction factor (␣TIF)/C1/Oct-1 multiprotein complex to the TAAGARAT (R, purine; GARAT) sequences of the cis-acting site (31) . Inhibition of any of these stages blocks HSV-1 replication. Nucleoside analogues have been extensively investigated in the search for effective antiherpesvirus agents (9) . Among these acyclovir is widely used for the systemic treatment of HSV infections. It is a highly selective antiviral agent because it is specifically phosphorylated by viral thymidine kinase in infected cells (10, 13) . However, acyclovirresistant HSV infection in immunocompromised patients such as transplant patients and patients with AIDS has recently been observed (6, 19) . Therefore, it is desirable to develop new anti-HSV agents that substitute for or complement acyclovir.
Chinese herbs are potential sources of useful edible and medicinal plants. They are expected to find use as functional foods because of their various biological activities such as immunomodulatory and antitumor functions (22, 23) . More and more people in developing countries utilize traditional medicine for their major primary health care needs (11, 17) . However, ethnopharmacology also provides scientists with an alternative approach for the discovery of antiviral agents. The polysaccharides (30) , anthraquinones (39) , triterpenes (38) , phloroglucinol (2) , flavonoids (26) , and catechin derivatives (12) isolated from medicinal plants have been found to have inhibitory activities against the replication of HSV-1. There has been a promising result for a naturally occurring antiherpetic agent, n-docosanol, which has recently completed extensive clinical evaluation and been approved by the U.S. Food and Drug Administration as a topical treatment for herpes labialis (1, 34, 36) . These findings show that natural products are still potential sources in the search for new antiherpetic agents.
In the present study, 10 Chinese herbs which are widely known in folk medicine for the treatment of viral and bacterial infection were selected for an anti-HSV-1 replication assay. The herbs were Ventilago leiocarpa, Ecdysanthera rosea, Ecdysanthera utilis, Hippobroma longiflora, Ardrisia brevicaulis, Selaginella delicatula, Limonium sinense, Ardrisia japonica, Ardrisia violacea, and Andendron benthamianum. The ethanolic extracts that showed appreciable anti-HSV-1 activity were separated by a bioassay-guided fractionation procedure. The effect of active component samarangenin B (Sam B), isolated from L. sinense, on HSV-1 ␣, ␤, and ␥ gene expression and DNA replication in Vero cells was evaluated. The mechanisms of antiviral action of Sam B were elucidated in vitro.
MATERIALS AND METHODS
Preparation of crude extracts for Chinese herbs. All 10 species of Chinese herbs were purchased from Chinese medicine shops in Taipei, Taiwan, and were identified by Lie-Chwen Lin. Each dried Chinese herb (600 g) was extracted with ethanol (three times in 5 liters). After solvent was removed, the crude extracts were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 100 mg/ml and stored at 4°C until use.
Sam B isolation from L. sinense. The method followed procedures described previously (26) . The ethanolic extract of the dried roots of L. sinense was partitioned in succession between H 2 O and n-hexane, followed by ethyl acetate and n-butanol (n-BuOH). The bioactive n-BuOH fraction was subjected to chromatography on Sephadex LH-20 with gradient methanol-H 2 O elution (from 0 to 100%) to produce 12 fractions. Sam B was identified from fraction 12 and analyzed with a high-performance liquid chromatography (HPLC) purity program. It was dissolved in DMSO to a concentration of 100 mM and stored at 4°C until use.
Cell culture and viruses. Vero cells were cultured in minimal essential medium (MEM; GIBCO, Grand Island, N.Y.) supplemented with 10% fetal calf serum (HyClone, Logan, Utah), 100 U of penicillin/ml, and 100 g of streptomycin/ml and incubated at 37°C in a 5% CO 2 incubator. The cells were free from mycoplasma contamination, which was checked by Mycotect kit (Life Technology, Gaithersburg, Md.). To prepare HSV-1 (KOS strain) stocks, Vero cells were infected by HSV-1 at a multiplicity of infection (MOI) of 3 and harvested at 24 h postinfection (p.i.) and centrifuged at 1,500 ϫ g (CR312; Jouan, Nantes, France) at 4°C for 20 min. The supernatant was collected and stored at Ϫ70°C for use.
Plaque reduction assay. The assay followed procedures described previously (24) . Acyclovir was used as a positive control. Vero cells (3.5 ϫ 10 5 /dish) were incubated with 100 PFU of HSV-1, and the test extracts or acyclovir was added to the cells at various concentrations. The viruses were adsorbed for 1 h at 37°C, and 1% methylcellulose was added to each well. After 5 days, the virus plaques formed in Vero cells were counted by crystal violet staining. The activities of test extracts and acyclovir for inhibition of plaque formation were calculated.
Determination of cell viability. Approximately 3.5 ϫ 10 5 Vero cells were cultured in a 25-cm 2 flask and incubated with 0.1% DMSO or 25 M Sam B for 5 days. Total, viable, and nonviable cells were counted three times under the microscope with the help of a hemocytometer following staining by trypan blue. The percentage of viable cells was calculated. The cell viability was also evaluated as lactate dehydrogenase (LDH) release according to the manufacturer's instructions (Roche, Milan, Italy). LDH activity in milliunits per milliliter, where 1 mU is the amount of enzyme required to transform 0.0167 nM NAD per min, was determined.
Effect of Sam B on Vero cell growth. The method was modified from that previously described (22) . For the analysis of total cellular protein synthesis, Vero cells were preincubated with leucine-free MEM for 1 day and then cultured in MEM containing 2% fetal calf serum. The cells (5 ϫ 10 3 /well) were incubated with or without Sam B at various concentrations for 5 days. Then, for detection of DNA, RNA, and protein synthesis in Vero cells, tritiated thymidine, tritiated uridine, or tritiated leucine was added into each well (1 Ci/well; NEN), respectively. After a 16-h incubation, the cells were harvested on glass fiber filters by an automatic harvester (Multimash 2000; Dynatech, Billingshurst, United Kingdom). Radioactivity in the filters was measured by scintillation counting.
Extraction of total cellular DNA and RNA. Cellular DNA and RNA were extracted from Vero cells by the method described previously (25, 24) . Vero cells (5 ϫ 10 6 ) were infected with HSV-1 at an MOI of 3 or were not infected in the presence or absence of Sam B (25 M) and harvested at various times. For DNA extraction, the cells were lysed with 0.2 M Tris-HCl (pH 8.5) containing 100 mM EDTA, 100 mM NaCl, 0.5% NP-40, 1% sodium dodecyl sulfate (SDS), and 100 g of proteinase K/ml. To extract cellular RNA, Vero cells were washed by cold Tris-saline (pH 7.4) and then suspended in NDD buffer (1% NP-40, 0.5% sodium deoxycholate, 1% dextran sulfate). The DNA and RNA solutions were extracted with phenol-chloroform and precipitated with 100% cold ethanol, and their concentrations were determined by measuring the optical density at 260 nm.
Synthesis of first-strand cDNA. The method followed procedures described previously (24) . Aliquots of 1 g of RNA were reverse transcribed with the Advantage RT-for-PCR kit from Clontech according to the manufacturer's instructions. The reaction mixture was initially incubated at 42°C for 1 h and then at 94°C for 5 min to terminate the reaction. Diethyl pyrocarbonate-treated H 2 O (80 l) was added to the tube, and the tube was then stored at Ϫ20°C for use in the PCR.
PCR. The method has been described elsewhere (24, 37) . Briefly, 10 l of cDNA or total cellular DNA was mixed with 0.75 M primers, 4 U of Taq polymerase, 10 l of reaction buffer (2 mM Tris-HCl [pH 8.0], 0.01 mM EDTA, 0.1 mM dithiothreitol, 0.1% Triton X-100, 5% glycerol, 1.5 mM MgCl 2 ), and 25 l of water in a total volume of 50 l. The oligonucleotide primer pairs were as follows: for gB (amplification fragment, 341 bp), 5Ј-CTGGTCAGCTTTCGGT ACGA-3Ј and 3Ј-CGTTTGTCGACGTGCTGGAC-5Ј; for HSV-1 DNA polymerase (600 bp), 5Ј-CGCACCATCTACGACGGCCAGC-3Ј and 3Ј-CGCTTTC GTCTAGGCGAGCGCC-5Ј; for ICP0 (157 bp), 5Ј-TTCGGTCTCCGCCTGA GAGT-3Ј and 3Ј-AGCATACGCCGACCTCCCAG-5Ј; for ICP4 (670 bp), 5Ј-C CCGCCGATGCTGCCCTAAAC-3Ј and 3Ј-TTCGCCAGACACCTACTCAA G-5Ј; for ␤-actin (1,300 bp), 5Ј-TTGAGACCTTCAACACCC-3Ј and 3Ј-CTCTACTGAAGCTTTTCGACT (7). The PCR was done at the following settings of the air thermocycler: denaturing temperature of 94°C for 1 min, annealing temperature of 53°C for 1 min, and elongation temperatures of 72°C for 2 min for the first 25 cycles and then 72°C for 10 min. The amplified products were quantitated with laser scanning densitometer SLR-2D/1D (Biomed Instruments Inc., Fullerton, Calif.).
Northern blot analysis. The analysis was modified from that previously described (24) . The HSV-1-infected (MOI, 3) Vero cells (5 ϫ 10 6 ) were cultured with or without Sam B (25 M) for 6 h. A 15-g sample of total cellular RNA was resolved on a 6.66% formaldehyde-agarose gel and then transferred to a nitrocellulose filter (Schleicher & Schuell) with 20ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The filter was prehybridized at 42°C for 4 h (prehybridization solution of 0.1% sodium pyrophosphate, 0.25 mg of denatured salmon sperm DNA/ml, and 50% deionized formamide). A digoxigenin-dUTP (Boehringer GmbH, Mannheim, Germany)-labeled DNA polymerase probe prepared by PCR was added to the same solution and incubated at 42°C for 12 h. The filter was washed with 0.1ϫ SSC, detected by enzyme immunoassay using an antibody conjugated to alkaline phosphatase (Boehringer GmbH), and visualized by the chemiluminescence recorded on X-ray film (Kodak).
Western blot analysis. The experiment followed procedures described previously (24) . The 5 ϫ 10 6 Vero cells were infected with HSV-1 at an MOI of 3 or were not infected in the presence or absence of Sam B (25 M) for 16 h. Extracted cellular proteins (20 g) were dissolved in the dissociation buffer (2% SDS, 5% ␤-mercaptoethanol, 0.05 M Tris-HCl, 20% glycerol, pH 7.6) and resolved by SDS-10% polyacrylamide gel electrophoresis (PAGE) then transferred to nitrocellulose filters. After filters were blocked, they were incubated with mouse monoclonal antibodies (Virusys Corporation, East Coast Biologics, Inc., North Berwick, Maine) raised against HSV-1 ␥ proteins (gB, gC, gD, gG, or ICP5) and ␣ proteins (ICP0 or ICP4). Specific reactive proteins were detected by an enhanced chemiluminescence method employing a rabbit anti-mouse immunoglobulin antibody linked to horseradish peroxidase (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.).
Electrophoretic mobility shift assay (EMSA). Oligonucleotide sequences 5Ј-GATCCCGTGCATGCTAATGATATTCTTTGGG-3Ј and 3Ј-GGCACGTAC GATTACTATAAGAAACCCCTAG-5Ј, corresponding to consensus ␣TIF/C1/ Oct-1 site (nucleotides Ϫ170 to Ϫ143) of the ICP0 gene were used as a probe. Nuclear extracts of HSV-1-infected Vero cells were prepared 5 h after infecting cells at an MOI of 20. Reaction mixtures (15 l) contained, together with 3 g of nuclear extracts, 5 ϫ 10 4 dpm of 32 P-end-labeled probe, 2 g of poly(dI-dC), 5% glycerol, 1 mM EDTA, 100 mM KCl, 5 mM MgCl 2 , 1 mM dithiothreitol, and Statistical analysis. Data were presented as means Ϯ standard deviations, and the differences between groups were assessed with Student's t test. Sam B identified from L. sinense inhibits HSV-1 replication. To extract pure active compounds from L. sinense, we used the complete isolation process in each chromatographic cycle and finally HPLC. The compound with the strongest activity was a brown amorphous powder. Nuclear magnetic resonance (NMR) and mass spectrum analyses indicated the structure shown in Fig. 2 . The chemical name of this bioactive component is galloyl-epigallocatechin ([4␤38, 2Ј33Љ-O]-galloyl-epigallocatechin; C 44 H 31 O 22 ; molecular weight, 911). Both mass and NMR spectrum data for the compound were compatible with those previously reported for Sam B by Nonaka et al. (32) . The common name given to this component at that time was Sam B. The purity of Sam B was assessed by an HPLC purity program (column 5C18-MS). The column was eluted with a 35:65 (vol/vol) mixture of methanol and 0.1% H 3 PO 4 and analyzed by a UV detector at 254 nm. Sam B appeared as a single peak at a 3.973-min retention time, and its purity was 99.0%.
RESULTS

Effects of ethanolic extracts from 10
As shown in Fig. 3 , Sam B blocked virus amplification, and thus its presence resulted in the formation of a cytopathic effect significant lower than that in control infections. The results of plaque reduction assay indicated that the inhibitory effect of Sam B on HSV-1 replication was concentration dependent. At 6.25 M, Sam B suppressed HSV-1 replication by 24.6% Ϯ 4.2%. The corresponding degrees of inhibition for 12.5, 25, 50, and 100 M were 58.3 Ϯ 3.0, 88.5 Ϯ 7.3, 100 Ϯ 5.2, and 100% Ϯ 2.2%, respectively, with an IC 50 value of 11.4 Ϯ 0.9 M (Fig. 4A) . 3 /well of a 96-well plate) were treated with Sam B at the indicated concentrations or were treated without Sam B for 5 days. Then tritiated thymidine, tritiated uridine, or tritiated leucine was added to each well (1 Ci/well) to detect cell growth. After a 16-h incubation, the cells were harvested by an automatic harvester and then radioactivity was measured by scintillation counting. Each bar represents the mean of three independent experiments. indicated that little signal was expressed in the cells treated with HSV-1 and Sam B at the same time.
Because production of gB proteins in Vero cells was attenuated, we determined whether gB mRNA expression in the cells was affected by Sam B. At 16 h p.i., the total cellular RNA was collected from Vero cells in the presence or absence of Sam B (25 M) and was available for reverse transcription-PCR (RT-PCR). Initially, we examined the dose-response relationship of the PCR amplification of cDNA (data not shown). The exponential phase of amplification was determined by performing 20, 25, and 30 cycles. We found that 25 cycles of PCR were optimal for the virion and ␤-actin mRNAs. interruption in the formation of ␣TIF/C1/Oct-1/GARAT multiprotein complexes.
DISCUSSION
The plaque reduction assay offers a popular system to evaluate the effect of antiviral agents against HSV-1 (3). In our study, 10 Chinese herbs were screened by this model and L. sinense was found to contain antiherpetic agents, supporting the validity of its use for pharmacological studies. genes regulates the ␤ genes to be expressed; (iii) both ␣ and ␤ gene expression initiates HSV-1 DNA replication; (iv) ␥ genes are synthesized, and then virions are assembled; and (v) HSV-1 is enveloped as it buds through the nuclear membrane (18, 28, 35) . In the present study, we found that Sam B decreased ICP0 and ICP4 gene expression in Vero cells. We are currently attempting to further elucidate whether the mechanisms by which Sam B suppresses ICP0 and ICP4 gene expression are related to the initial transcriptional transactivation events, including formation of ␣TIF/C1/Oct-1/GARAT multiprotein complexes. Our initial experiments using EMSA indicated that retarded species IEC has been decreased in the GARAT probes incubated with Sam B-treated nuclear extracts infected by HSV-1. Thus, the possibility that Sam B inhibited HSV-1 replication through disturbance of ␣TIF/C1/Oct-1/GARAT stable complex formation cannot be excluded. ICP0 has been reported to perform several functions including selection of transcriptional termination sites and stimulation of DNA synthesis. Although ICP0 is not essential for HSV-1 replication in some cell cultures, defects in the associated gene delay the expression of ␤ and ␥ genes and impair viral replication (35) . ICP4 is the major transactivator of HSV-1 genes. Thus, ICP4 and ICP0 play important roles in regulation of ␤ and ␥ gene expression and are essential for HSV-1 replication (14) . Moreover, the present data indicated that Sam B impaired DNA polymerase transcripts and HSV-1 DNA synthesis in Vero cells. It is known that a large array of proteins including DNA polymerase are required for HSV-1 DNA synthesis. We suggest that the decrease in HSV-1 DNA synthesis due to Sam B is related to impairment of DNA polymerase. Recently, we detected thymidine kinase mRNA expression in Vero cells by RT-PCR, and preliminary results indicate that Sam B impeded thymidine kinase mRNA expression (data not shown). We also proved that the production of gB, gC, gD, gG, and ICP5 proteins in Vero cells was attenuated by Sam B. ICP5 is a major capsid protein and is made both early and late in infection. gB, gC, gD, and gG are all involved in the viral envelope structure and play important roles in viral attachment and penetration. The evidence demonstrates that ICP4 is required for expression of ␥ genes and that ICP4 binding sites enhance the transcription of the gD gene in vitro (15) . Although effects of Sam B on gC, gD, gG, and ICP5 mRNA expression were not determined, it was found that Sam B decreased gB mRNA expression in Vero cells. HSV-1 DNA synthesis is required for gC mRNA expression. gD, gG, and ICP5 are similar to gB in that their mRNA expression requires ICP4 proteins (34) . Thus, we predict that Sam B attenuates levels of gB, gC, gD, gG, and ICP5 proteins in Vero cells, which may be related to impairment of DNA synthesis and ICP4 and ICP0 production. The attenuation of DNA synthesis and ICP4 and ICP0 production may cause decreases of gB, gC, gD, gG, and ICP5 gene expression in Vero cells.
From the present results, we hypothesize that impairment of HSV-1 multiplication in Sam B-treated Vero cells, at least in part, was related to (i) decreases in HSV-1 ICP0 and ICP4 gene expression due to Sam B, which might be related to disturbance of the formation of ␣TIF/C1/Oct-1/GARAT multiprotein complexes, (ii) reduction in DNA polymerase transcriptions in the cells, (iii) inhibition of viral DNA synthesis, (iv) interference with gB protein synthesis due to blockage of gB mRNA synthesis, (v) impaired levels of viral capsid protein ICP5 and envelope proteins gC, gD, and gG, and (vi) no HSV-1 plaque formation in Vero cells. Unlike dextran sulfate isolated from Sargassum horneri, which inhibits HSV-1 replication at the adsorption step (16) , Sam B blocked HSV-1 replication at the immediate-early and early steps. The expression of the immediate-early gene represents one stage of the HSV-1 replication cycle that could be targeted by a novel antiviral therapy to deliver a significant reduction in virus replication in both acute and latent infections. The expression of the immediate-early gene plays important roles in the regulation of all classes of viral genes during lytic infection and is the key initiating event in the process of reactivation of the latent HSV-1 genomes. Low levels of immediate-early transcripts can be identified in latently infected neuron cells. ICP0 mutant viruses that are defective in immediate-early transactivation have been shown to reactivate very poorly from latent infections (35) . While nucleoside analogues have been successful in treating acute infections, they fail to modulate reactivation of latent virus. On the other hand, Sam B lacked the elevated cytotoxicity and antiproliferative properties of interferons (4) . Because Vero cells are notoriously hardy and aneuploid, the effects of Sam B on the growth of human peripheral blood mononuclear cells (PBMC), which are normal diploid cells, were determined. Results indicated that Sam B did not affect DNA, RNA, and protein synthesis in PBMC (data not shown) and that the therapeutic index was about 13.2. Thus, small molecules identified from Chinese herbs such as Sam B which act as inhibitors of HSV-1 immediate-early gene expression may have the potential to impact clinical disease to a far greater extent than currently marketed nucleosides and cytokines. Future experiments with treatment of HSV-1-infected animals with Sam B will be necessary to define whether L. sinense can reduce experimental viral infection injury and prevent recurrent HSV-1 infection. Moreover, this study not only demonstrates that Chinese herbs are potential therapeutic drugs for the viral infection but also supports a model for future protocol design in preclinical studies.
